Published in Cytotechnology on September 01, 2003
An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma. PLoS One (2012) 0.81
Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen. J Transl Med (2015) 0.77
Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients. Stem Cells Transl Med (2015) 0.76
Human CD8(+) T cells transduced with an additional receptor bispecific for both Mycobacterium tuberculosis and HIV-1 recognize both epitopes. J Cell Mol Med (2016) 0.75
Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6. Cytotechnology (2011) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Proliferating dendritic cell progenitors in human blood. J Exp Med (1994) 7.67
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature (1992) 7.41
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods (1996) 4.87
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med (2001) 4.78
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods (1996) 3.80
The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol (2000) 3.71
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol (1995) 3.39
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods (1999) 3.09
Retracted Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med (2000) 2.64
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood (2002) 2.61
Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med (1999) 2.37
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood (2002) 2.30
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med (2002) 2.07
Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol (1996) 1.99
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc Natl Acad Sci U S A (1995) 1.49
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer (2000) 1.32
Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother (2001) 1.23
Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J Immunol Methods (2002) 1.08
Tumor escape from immune surveillance. Arch Immunol Ther Exp (Warsz) (1999) 1.03
The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol Prog (2000) 0.90
Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells. J Hematother Stem Cell Res (2000) 0.85
Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale. Cytotechnology (2002) 0.83
Simplified method to generate large quantities of dendritic cells suitable for clinical applications. Immunol Invest (2000) 0.81
Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use. Hematol Cell Ther (1998) 0.81
Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications. J Immunol Methods (2002) 0.79
Regression of lymph node metastases by immunotherapy using autologous breast tumor-lysate pulsed dendritic cells: report of a case. Surg Today (2001) 0.78
Enzymic determination of inorganic phosphates, organic phosphates and phosphate-liberating enzymes by use of nucleoside phosphorylase-xanthine oxidase (dehydrogenase)-coupled reactions. Biochem J (1985) 1.64
Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell. Cardiovasc Res (1994) 1.57
Energetic response of coronary endothelial cells to hypoxia. Am J Physiol (1990) 1.07
Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol (1996) 1.03
Human basophils release interleukin-4 after stimulation with Schistosoma mansoni egg antigen. Eur J Immunol (1996) 1.02
The crucial role of low steady state oxygen partial pressures in haloalkane free-radical-mediated lipid peroxidation. Possible implications in haloalkane liver injury. Biochem Pharmacol (1986) 1.00
Opposite effect of cAMP signaling in endothelial barriers of different origin. Am J Physiol Cell Physiol (2004) 1.00
Mechanism of Ca(2+) overload in endothelial cells exposed to simulated ischemia. Cardiovasc Res (2000) 0.93
Calcium antagonists ameliorate ischemia-induced endothelial cell permeability by inhibiting protein kinase C. Circulation (1999) 0.91
Blockade of Ca2+-activated K+ channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J Vasc Res (1998) 0.88
Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium. J Biotechnol (2004) 0.88
Oxygen dependence and subcellular partitioning of hepatic menadione-mediated oxygen uptake. Studies with isolated hepatocytes, mitochondria, and microsomes from rat liver in an oxystat system. Arch Biochem Biophys (1985) 0.88
Halothane-induced lipid peroxidation and glucose-6-phosphatase inactivation in microsomes under hypoxic conditions. Anesthesiology (1985) 0.87
Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Br J Pharmacol (2012) 0.87
Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells. Am J Physiol (1993) 0.87
Oxygen gradients: the problem of hypoxia. Biochem Soc Trans (1987) 0.86
Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability. Am J Physiol (1998) 0.85
Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells. Am J Physiol Cell Physiol (2010) 0.85
Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response. J Exp Med (1998) 0.85
Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am J Physiol (1996) 0.84
[The predictive quality of the Psychopathy Checklist-Revised (PCL-R) for violent and sex offenders in Switzerland. A validation study]. Fortschr Neurol Psychiatr (2006) 0.84
Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood--a comparative study. Stem Cells Dev (2010) 0.84
Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale. Cytotechnology (2002) 0.83
The crucial role of hypoxia in halothane-induced lipid peroxidation. Biochem Biophys Res Commun (1984) 0.82
Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J Vasc Res (2000) 0.82
Effects of high passage cultivation on CHO cells: a global analysis. Appl Microbiol Biotechnol (2012) 0.81
Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability. Vasa (1999) 0.81
Distinct temporal relation among oxygen uptake, malondialdehyde formation, and low-level chemiluminescence during microsomal lipid peroxidation. Arch Biochem Biophys (1987) 0.81
Halothane hepatotoxicity: relation between metabolic activation, hypoxia, covalent binding, lipid peroxidation and liver cell damage. Hepatology (1983) 0.81
Dual role of cGMP in modulation of macromolecule permeability of aortic endothelial cells. Am J Physiol (1997) 0.80
Dependence of hepatic gluconeogenesis on PO2: inhibitory effects of halothane. J Appl Physiol (1985) (1987) 0.80
The role of physiological oxygen partial pressures in lipid peroxidation. Theoretical considerations and experimental evidence. Chem Phys Lipids (1987) 0.80
Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease. Ann N Y Acad Sci (2001) 0.79
Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells. Cardiovasc Res (2007) 0.79
Spatio-temporal coherence of free electron laser pulses in the soft x-ray regime. Opt Express (2008) 0.79
Leishmania major: histone H1 gene expression from the sw3 locus. Exp Parasitol (1999) 0.79
Vinculin phosphorylation and barrier failure of coronary endothelial monolayers under energy depletion. Am J Physiol (1997) 0.78
The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability. J Pharmacol Exp Ther (1999) 0.78
Modulation of early [Ca2+]i rise in metabolically inhibited endothelial cells by xestospongin C. Am J Physiol Heart Circ Physiol (2001) 0.78
A computer-supported oxystat system maintaining steady-state O2 partial pressures and simultaneously monitoring O2 uptake in biological systems. Biochem J (1986) 0.78
A three-step procedure for the purification of human basophils from buffy coat blood. Inflamm Res (1997) 0.77
The critical steady-state hypoxic conditions in carbon tetrachloride-induced lipid peroxidation in rat liver microsomes. Biochim Biophys Acta (1984) 0.77
Halomethane hepatotoxicity: induction of lipid peroxidation and inactivation of cytochrome P-450 in rat liver microsomes under low oxygen partial pressures. Toxicol Appl Pharmacol (1989) 0.77
Dependence of mitochondrial and cytosolic adenine nucleotides on oxygen partial pressure in isolated hepatocytes. Application of a new rapid high pressure filtration technique for fractionation. Biochem J (1988) 0.77
beta-agonistic bronchodilators: comparison of dose/response in working rat hearts. Chest (2000) 0.76
Endothelial cell toxicity of preservation solutions: comparison of endothelial cells of different origin and dependence on growth state. Cryobiology (1994) 0.76
Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats. Biomaterials (2005) 0.76
Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge. Br J Cancer (2008) 0.75
Lipid peroxidation and cell viability in isolated hepatocytes in a redesigned oxystat system: evaluation of the hypothesis that lipid peroxidation, preferentially induced at low oxygen partial pressures, is decisive for CCl4 liver cell injury. Arch Biochem Biophys (1988) 0.75
[Factor XIII: experimental and clinical results in diabetic foot ulcer]. Zentralbl Chir (1999) 0.75
[Mechanisms influencing cellular physiology as a concept of treatment for wound healing disturbances]. Zentralbl Chir (2005) 0.75
Extracellular ATP attenuates ischemia-induced caspase-3 cleavage in human endothelial cells. Biochem Biophys Res Commun (2012) 0.75
Loss of latent activity of liver microsomal membrane enzymes evoked by lipid peroxidation. Studies of nucleoside diphosphatase, glucose-6-phosphatase, and UDP glucuronyltransferase. Biochim Biophys Acta (1985) 0.75
CellViCAM--Cell viability classification for animal cell cultures using dark field micrographs. J Biotechnol (2010) 0.75
MEK/MAPK as a signaling element in ATP control of endothelial myosin light chain. Am J Physiol Cell Physiol (2004) 0.75
Cytosolic Ca2+ overload and macromolecule permeability of endothelial monolayers. Herz (1992) 0.75
Alterations of the microsomal glucose-6-phosphatase system evoked by ferrous iron- and haloalkane free-radical-mediated lipid peroxidation. Biochim Biophys Acta (1986) 0.75
Suicidal inactivation of microsomal cytochrome P-450 by halothane under hypoxic conditions. Biochem Biophys Res Commun (1982) 0.75